Extended Data Fig. 6: Patient 12, % change from baseline over time.
From: In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial
The percent change in wound surface area for both B-VEC and placebo wounds was calculated over the course of treatment of Patient 12 and was plotted as a bar graph (end of cycle, % change area of wound from baseline). B-VEC, beremagene geperpavec.
